PubMed=24463987; DOI=10.1038/ncomms4195
Rodin S., Antonsson L., Niaudet C., Simonson O.E., Salmela E., Hansson E.M., Domogatskaya A., Xiao Z.-J., Damdimopoulou P., Sheikhi M., Inzunza J., Nilsson A.-S., Baker D.E.C., Kuiper R., Sun Y., Blennow E., Nordenskjold M., Grinnemo K.-H., Kere J., Betsholtz C., Hovatta O., Tryggvason K.
Clonal culturing of human embryonic stem cells on laminin-521/E-cadherin matrix in defined and xeno-free environment.
Nat. Commun. 5:3195.1-3195.13(2014)

PubMed=28445466; DOI=10.1038/nature22312; PMCID=PMC5427175
Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C., Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G., Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A., Eggan K.C.
Human pluripotent stem cells recurrently acquire and expand dominant negative p53 mutations.
Nature 545:229-233(2017)

PubMed=32339905; DOI=10.1016/j.scr.2020.101810
Main H., Hedenskog M., Acharya G., Hovatta O., Lanner F.
Karolinska Institutet Human Embryonic Stem Cell Bank.
Stem Cell Res. 45:101810-101810(2020)